-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A clinical study by the Indiana University School of Medicine and the Regenstrief Institute examined the use of FIT (fecal immunochemical testing) in emergency and hospital patients, which looks for blood in the stool, which is a possible sign of colorectal cancer
"FIT is a cancer screening tool, not a test for symptoms, such as rectal bleeding, abdominal pain, or changes in bowel habits," the co-author of the study, the Regenstrive Institute and Indiana University Medicine Thomas F.
Dr.
The study authors’ review of electronic medical records (emr) revealed that from November 2017 to October 2019, 203,667 patients were evaluated or hospitalized in the emergency department, during which only 550 fit cases were identified
Dr.